Experimental drug duo tested in advanced bladder cancer patients
NCT ID NCT04004442
Summary
This early-stage study is testing whether combining two drugs—avelumab and AVB-S6-500—is safe for people with advanced bladder cancer that has spread or can't be surgically removed. The trial involves 19 participants who have already tried standard platinum-based chemotherapy. Researchers will monitor patients closely to find the highest dose they can tolerate while checking if the combination helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.